Interferon‐γ inhibits tumor antigen presentation by epidermal antigen‐presenting cells

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Leukocyte Biology

• Publication date

  1994-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jlb.55.6.695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor antigen presentation by epidermal antigen‐presenting cells in the mouse: modulation by granulocyte‐macrophage colony‐stimulating factor, tumor necrosis factor α, and ultraviolet radiation

  1992cited by this paper
• Role of anterior-chamber-associated immune deviation in the pathogenesis of uveitis.

  1992cited by this paper
• Role of Anterior-Chamber-Associated Immune Deviation in the Pathogenesis of Uveitis1

  1992cited by this paper
• Early molecular events in the induction phase of contact sensitivity.

  1992cited by this paper
• CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

  1992cited by this paper
• CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes

  1992cited by this paper
• Inducibility of class II major histocompatibility complex antigens by interferon gamma is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras

  1991cited by this paper
• Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

  1991cited by this paper
• Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway.

  1991cited by this paper
• Comparison of effects of transforming growth factor-beta and cyclosporin A on antigen-presenting cells of blood and epidermis.

  1991cited by this paper
• IFN-gamma induces the expression of the genes for MHC class II I-A beta and tumor necrosis factor through a protein kinase C-independent pathway.

  1991cited by this paper
• Upregulation of Interferon-γ Binding by Tumor Necrosis Factor and Lymphotoxin: Disparate Potencies of the Cytokines and Modulation of Their Effects by Phorbol Ester

  1991cited by this paper
• Phorbol myristate acetate-activated keratinocytes stimulate proliferation of resting peripheral blood mononuclear lymphocytes via a MHC-independent, but protein kinase C- and intercellular adhesion molecule-1-dependent, mechanism.

  1991cited by this paper
• Tumor antigen presentation by murine epidermal cells.

  1991cited by this paper
• Activation of macrophages for ADCC in vitro: Effects of IL-4, TNF, interferons-αβ, interferon-γ, and GM-CSF

  1991cited by this paper
• Induction of tumor necrosis factor-alpha and its receptors during differentiation in myeloid leukemic cells along the monocytic pathway. A possible regulatory mechanism for TNF-alpha production.

  1990cited by this paper
• Myelopoiesis‐associated suppressor‐cell activity in mice with lewis lung carcinoma tumors: Interferon‐γ plus tumor necrosis factor‐α synergistically reduce suppressor cell activity

  1990cited by this paper
• Augmentation of tumor antigen expression by recombinant human interferons: enhanced targeting of monoclonal antibodies to carcinomas.

  1990cited by this paper
• Incidence of skin cancer after renal transplantation in The Netherlands.

  1990cited by this paper
• Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-gamma plus tumor necrosis factor-alpha synergistically reduce suppressor cell activity.

  1990cited by this paper
• Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.

  1989cited by this paper
• Modulation of Ovarian Carcinoma Tumor Marker CA-125 by γ-Interferon

  1989cited by this paper
• Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.

  1989cited by this paper
• Gamma Interferon Induces the Appearance of a CD4‐, Major Histocompatibility Complex Class II+ Macrophage Subpopulation in the Rat Peritoneal Cavity

  1989cited by this paper
• Modulation of ovarian carcinoma tumor marker CA-125 by gamma-interferon.

  1989cited by this paper
• Enhancement of DTH reaction and inhibition of the expression of class II transplantation antigens by in vivo treatment with antibodies against gamma-interferon.

  1988cited by this paper
• Synergistic enhancement of the antitumor activity of recombinant human TNF-alpha by recombinant human IFN-gamma.

  1988cited by this paper
• Serological characterization of macrophage hybridomas: identification of an interferon-gamma-inducible surface marker.

  1988cited by this paper
• Recombinant gamma interferon increases the binding of peripheral blood mononuclear leukocytes and a Leu-3+ T lymphocyte clone to cultured keratinocytes and to a malignant cutaneous squamous carcinoma cell line that is blocked by antibody against the LFA-1 molecule.

  1988cited by this paper
• Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts.

  1987cited by this paper
• Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells

  1987cited by this paper
• Epidermal cells in activation of suppressor lymphocytes: further characterization.

  1987cited by this paper
• Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

  1986cited by this paper
• Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype

  1986cited by this paper
• Cutaneous malignant neoplasms in patients with renal transplants.

  1986cited by this paper
• Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells.

  1986cited by this paper
• T cell induction of membrane IL 1 on macrophages.

  1986cited by this paper
• Recombinant Gamma Interferon Differentially Regulates Class II Antigen Expression and Biosynthesis on Cultured Normal Human Keratinocytes

  1985cited by this paper
• Modulation of suppressor T cell induction with gamma-interferon.

  1985cited by this paper
• Characterization of the accessory cells involved in suppressor T cell induction.

  1985cited by this paper
• Immunological Unresponsiveness Induced by Ultraviolet Radiation

  1984cited by this paper
• Differential antigen presentation in tumor immunity.

  1984cited by this paper
• Langerhans cells as stimulator cells in the murine primary epidermal cell-lymphocyte reaction: alteration by UV-B irradiation.

  1982cited by this paper
• The role of T cell sets in the rejection of a methylcholanthrene-induced sarcoma (S1509a) in syngeneic mice.

  1981cited by this paper
• Immunologic mechanisms in UV radiation carcinogenesis.

  1981cited by this paper
• Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.

  1979cited by this paper
• Incidence of skin carcinoma after renal transplantation.

  1977cited by this paper

• Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?

  2021cites this paper
• The molecular mechanisms supporting the homeostasis and activation of dendritic epidermal T cell and its role in promoting wound healing

  2021cites this paper
• Molecular and immunologic markers of kidney cancer—potential applications in predictive, preventive and personalized medicine

  2015cites this paper
• UV Induced Skin Immunosuppression

  2009cites this paper
• The class 6 semaphorin SEMA6A is induced by interferon-gamma and defines an activation status of langerhans cells observed in pathological situations.

  2006cites this paper
• Immunologic approaches to breast cancer treatment.

  2005cites this paper
• Immunotherapeutic Approaches for the Treatment of Breast Cancer

  2004cites this paper
• Microarray analysis of UVB-regulated genes in keratinocytes: downregulation of angiogenesis inhibitor thrombospondin-1.

  2004cites this paper
• Cells as Vehicles for Cancer Gene Therapy: The Missing Link Between Targeted Vectors and Systemic Delivery?

  2002cites this paper
• RNA as a tumor vaccine: a review of the literature

  2001cites this paper
• CHAPTER 42 – Dendritic cell tolerogenicity and prospects for dendritic cell-based therapy of allograft rejection and autoimmune disease

  2001cites this paper
• Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA.

  2000cites this paper
• Granulocyte-macrophage colony-stimulating factor gene transfer to dendritic cells or epidermal cells augments their antigen-presenting function including induction of anti-tumor immunity.

  1999cites this paper
• IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.

  1998cites this paper
• Tumor‐induced immune dysfunction: the macrophage connection

  1998cites this paper
• The role of cytokines in functional regulation and differentiation of dendritic cells.

  1996cites this paper
• Cytokines and Photocarcinogenesis

  1996cites this paper
• Les cellules de Langerhans : Utiles ou néfastes?

  1996cites this paper
• Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases.

  1995cites this paper
• THE ROLE OF EPIDERMAL CYTOKINES IN THE GENERATION OF CUTANEOUS IMMUNE REACTIONS and ULTRAVIOLET RADIATION‐INDUCED IMMUNE SUPPRESSION

  1995cites this paper
• Modulation of immunity by ultraviolet radiation: key effects on antigen presentation.

  1995cites this paper
• Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin

  1995cites this paper